🇺🇸 FDA
Patent

US 7666846

Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi

granted A61KA61K2039/6037A61K39/0225

Quick answer

US patent 7666846 (Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/6037, A61K39/0225, A61K47/6415, A61K47/643